Sana Biotechnology (SANA) shares have been trending higher over the past month, recording a 47% gain. This upward move comes as investors sort through recent developments and assess the company’s ...

Investing.com -- Sana Biotechnology Inc (NASDAQ:SANA) stock surged 20% Wednesday after EMJ Capital Eric Jackson declared the company could become "the next 100-bagger platform" in a series of posts on ...

Benzinga’s Edge Stock Rankings system scores stocks across key measures including momentum, growth, value and quality. The momentum score serves as a key indicator for traders looking to capitalize on ...

A new RNA biotech has risen with a $200 million series A in the tank and a team of seasoned biotech chefs ready to light the burners. Soufflé Therapeutics will cook up siRNA medicines that are ...

The U.S. is falling behind in biotechnology development, Sen. Todd Young, R-Ind., said Wednesday—adding that he and other lawmakers are working to help the country catch up with China’s push to ...

Ten months into 2025, and it’s clear the year hasn’t unfolded as many had expected—or hoped. Marked by a persistent bear market and compounded by geopolitical tensions and regulatory uncertainty, the ...

Investing.com -- Sana Biotechnology Inc (NASDAQ:SANA) stock surged 20% Wednesday after EMJ Capital Eric Jackson declared the company could become "the next 100-bagger platform" in a series of posts on ...

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...

Novo Nordisk said Thursday it was buying US biotech firm Akero Therapeutics, which is developing treatments for a number of metabolic diseases, for $4.7 billion. The Danish firm, the maker of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Watertown biotech is the ...